M&A

Teva closes $703m sale of global women’s health biz to CVC Capital
Drug Delivery Business News
Thu, 02/1/18 - 09:28 am
Teva Pharmaceutical
Women's Health
M&A
CVC Capital
Pharma M&A machine unstoppable: Seattle Genetics acquires Cascadian for $614m
GoinPharma
Wed, 01/31/18 - 11:15 am
Seattle Genetics
M&A
Cascadian
Pfizer benefits from tax reform, still vague on M&A
Biopharma Dive
Tue, 01/30/18 - 10:44 pm
Pfizer
tax reform
M&A
Sanofi CEO: $16 Billion Deal Binge Does Not Represent A Change In Strategy
Forbes
Mon, 01/29/18 - 03:26 pm
Sanofi
Pharma CEOs
Olivier Brandicourt
M&A
Ablynx
Bioverativ
Sanofi beats Novo to buy Ablynx for 3.9 billion euros in biotech M&A boom
Yahoo/Reuters
Mon, 01/29/18 - 10:33 am
Sanofi
Novo Nordisk
M&A
biotech
Ablynx
2 Biotech Acquisition Candidates That Could Be Next in M&A Crosshairs
TheStreet.com
Mon, 01/29/18 - 09:29 am
biotech
M&A
Bluebird Bio
Amicus Therapeutics
Hospital Mergers Jump 13% As CVS And Optum Enter Their Markets
Forbes
Mon, 01/29/18 - 09:23 am
hospitals
M&A
CVS Health
OptumRx
[video]Big Biotech Is Bustling With Buyouts
Motley Fool
Mon, 01/29/18 - 09:21 am
biotech
M&A
Celgene
Juno Therapeutics
Sanofi
Bioverativ
5 Things Celgene's Management Just Said That You'll Want to Know
Motley Fool
Sat, 01/27/18 - 09:39 am
Celgene
M&A
Juno Therapeutics
Impact Biomedicines
Otezla
drug pricing
U.S. SEC files suit over possible insider trading on Sanofi's purchase of Bioverativ
Yahoo/Reuters
Sat, 01/27/18 - 09:33 am
SEC
insider trading
Sanofi
M&A
Bioverativ
Biogen's in the hunt for late-stage assets, executives say amid Q4 revenue beat
Fierce Pharma
Fri, 01/26/18 - 09:35 am
Biogen
earnings
M&A
Behind the deal spree, Celgene continues to cautiously explore neurosciences
Endpoints
Fri, 01/26/18 - 09:09 am
Celgene
M&A
Neurosciences
Women’s health biotech KaNDy dickering with Allergan about a $400M buyout deal — report
Endpoints
Fri, 01/26/18 - 09:05 am
Women's Health
KaNDy
Allergan
M&A
Biogen: Where Is That Blockbuster Acquisition?
Forbes
Thu, 01/25/18 - 05:54 pm
Biogen
M&A
Celgene's task: Turn its shiny new toys into growth drivers
Biopharma Dive
Thu, 01/25/18 - 05:51 pm
Celgene
M&A
Juno Therapeutics
Impact Biomedicines
Johnson & Johnson drops out of the race for Pfizer consumer unit, paving the way for GSK, Reckitt
Fierce Pharma
Thu, 01/25/18 - 05:29 pm
JNJ
Pfizer
consumer health
M&A
GSK
Reckitt Benckiser
Boston Scientific puts $90m into Millepede
Mass Device
Wed, 01/24/18 - 09:11 am
Boston Scientific
devices
M&A
Millepede
Biotech M&A In 2018: A Tsunami Or A Ripple?
Forbes
Tue, 01/23/18 - 09:22 am
biotech
M&A
Sanofi
Bioverativ
Celgene
Juno Therapeutics
Bluebird Bio Shouldn’t Be Blue About Celgene’s Juno Deal
Washington Post, DC
Tue, 01/23/18 - 08:43 am
Bluebird Bio
Celgene
Juno Therapeutics
M&A
CAR-T
Celgene Buys Juno Therapeutics: A Risky $9B Bet
Forbes
Mon, 01/22/18 - 05:39 pm
Celgene
Juno Therapeutics
M&A

Pages